The human gammaherpesviruses Epstein–Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) both infect lymphoid and epithelial cells and both are implicated in the development of cancer. The two viruses establish latency in B-lymphoid cells that, once disrupted, leads to a burst of virus replication during the lytic cycle. A basic leucine zipper (bZIP) transcription factor encoded by EBV, Zta (also known as BZLF1 and ZEBRA), is key to the disruption of EBV latency. KSHV encodes a related protein, K-bZIP (also known as RAP and K8α). Recent developments in our understanding of the structures and functions of these two viral bZIP proteins have led to the conclusion that they are not homologues. Two important features of Zta are its ability to interact directly with DNA and to induce EBV replication whereas K-bZIP is not known to interact directly with DNA or to induce KSHV replication. Despite these differences, the ability to disrupt cell cycle control is conserved in both Zta and K-bZIP. The interactions of Zta and K-bZIP with cellular genes will be reviewed here.
AdamsonA. L.,
KenneyS. C.1998; Rescue of the Epstein–Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product. Virology 251:187–197
AdamsonA. L.,
KenneyS.1999; The Epstein–Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J Virol 73:6551–6558
BaumannM.,
GiresO.,
KolchW.,
MischakH.,
ZeidlerR.,
PichD.,
HammerschmidtW.2000; The PKC targeting protein RACK1 interacts with the Epstein–Barr virus activator protein BZLF1. Eur J Biochem 267:3891–3901
BellP.,
LiebermanP. M.,
MaulG. G.2000; Lytic but not latent replication of Epstein–Barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol 74:11800–11810
CayrolC.,
FlemingtonE.1996a; G0/G1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein–Barr virus transactivator Zta. J Biol Chem 271:31799–31802
ChenC. J.,
DengZ.,
KimA. Y.,
BlobelG. A.,
LiebermanP. M.2001; Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators. Mol Cell Biol 21:476–487
ChiT.,
CareyM.1996; Assembly of the isomerized TFIIA-TFIID-TATA ternary complex is necessary and sufficient for gene activation. Genes Dev 10:2540–2550
DreyfusD. H.,
NagasawaM.,
KelleherC. A.,
GelfandE. W.2000; Stable expression of Epstein–Barr virus BZLF-1-encoded ZEBRA protein activates p53-dependent transcription in human Jurkat T-lymphoblastoid cells. Blood 96:625–634
FeederleR.,
KostM.,
BaumannM.,
JanzA.,
DrouetE.,
HammerschmidtW.,
DelecluseH. J.2000; The Epstein–Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19:3080–3089
FrancisA. L.,
GradovilleL.,
MillerG.1997; Alteration of a single serine in the basic domain of the Epstein–Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency. J Virol 71:4543–4551
FrancisA.,
RagoczyT.,
GradovilleL.,
HestonL.,
El-GuindyA.,
EndoY.,
MillerG.1999; Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein–Barr virus R transactivator. J Virol 73:3054–3061
GruffatH.,
Portes-SentisS.,
SergeantA.,
ManetE.1999; Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) encodes a homologue of the Epstein–Barr virus bZip protein EB1. J Gen Virol 80:557–561
GutschD. E.,
Holley-GuthrieE. A.,
ZhangQ.,
SteinB.,
BlanarM. A.,
BaldwinA. S.,
KenneyS. C.1994; The bZIP transactivator of Epstein–Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF- κ B. Mol Cell Biol 14:1939–1948
HicksM. R.,
BalesariaS.,
Medina-PalazonC.,
PandyaM. J.,
WoolfsonD. N.,
SinclairA. J.2001; Biophysical analysis of natural variants of the multimerization region of Epstein–Barr virus lytic-switch protein BZLF1. J Virol 75:5381–5384
HongY.,
Holley-GuthrieE.,
KenneyS.1997; The bZip dimerization domain of the Epstein–Barr virus BZLF1 (Z) protein mediates lymphoid-specific negative regulation. Virology 229:36–48
HwangS.,
GwackY.,
ByunH.,
LimC.,
ChoeJ.2001; The Kaposi's sarcoma-associated herpesvirus K8 protein interacts with CREB-binding protein (CBP) and represses CBP-mediated transcription. J Virol 75:9509–9516
LiebermanP.1994; Identification of functional targets of the Zta transcriptional activator by formation of stable preinitiation complex intermediates. Mol Cell Biol 14:8365–8375
LiebermanP. M.,
BerkA. J.1991; The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction. Genes Dev 5:2441–2454
LiebermanP. M.,
BerkA. J.1994; A mechanism for TAFs in transcriptional activation: activation domain enhancement of TFIID-TFIIA-promoter DNA complex formation. Genes Dev 8:995–1006
LiebermanP. M.,
OzerJ.,
GurselD. B.1997; Requirement for transcription factor IIA (TFIIA)-TFIID recruitment by an activator depends on promoter structure and template competition. Mol Cell Biol 17:6624–6632
LinS. F.,
RobinsonD. R.,
MillerG.,
KungH. J.1999; Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein–Barr virus. J Virol 73:1909–1917
LukacD. M.,
RenneR.,
KirshnerJ. R.,
GanemD.1998; Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252:304–312
LukacD. M.,
KirshnerJ. R.,
GanemD.1999; Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73:9348–9361
MauserA.,
Holley-GuthrieE.,
SimpsonD.,
KaufmannW.,
KenneyS.2002a; The Epstein–Barr virus immediate-early protein BZLF1 induces both a G2 and a mitotic block. J Virol 76:10030–10037
MauserA.,
Holley-GuthrieE.,
ZanationA.,
YarboroughW.,
KaufmannW.,
KlingelhutzA.,
SeamanW. T.,
KenneyS.2002b; The Epstein–Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. J Virol 76:12543–12552
MauserA.,
SaitoS.,
AppellaE.,
AndersonC. W.,
SeamanW. T.,
KenneyS.2002c; The Epstein–Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J Virol 76:12503–12512
OzerJ.,
BoldenA. H.,
LiebermanP. M.1996; Transcription factor IIA mutations show activator-specific defects and reveal a IIA function distinct from stimulation of TBP-DNA binding. J Biol Chem 271:11182–11190
ParkJ.,
SeoT.,
HwangS. M.,
LeeD.,
GwackY.,
ChoeJ.2000; The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity. J Virol 74:11977–11982
PfitznerE.,
BeckerP.,
RolkeA.,
SchuleR.1995; Functional antagonism between the retinoic acid receptor and the viral transactivator BZLF1 is mediated by protein-protein interactions. Proc Natl Acad Sci U S A 92:12265–12269
PolsonA. G.,
HuangL.,
LukacD. M.,
BlethrowJ. D.,
MorganD. O.,
BurlingameA. L.,
GanemD.2001; Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J Virol 75:3175–3184
Portes-SentisS.,
ManetE.,
GourruG.,
SergeantA.,
GruffatH.2001; Identification of a short amino acid sequence essential for efficient nuclear targeting of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 K8 protein. J Gen Virol 82:507–512
RagoczyT.,
HestonL.,
MillerG.1998; The Epstein–Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J Virol 72:7978–7984
RodriguezA.,
JungE. J.,
YinQ.,
CayrolC.,
FlemingtonE. K.2001; Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest. Virology 284:159–169
RussoJ. J.,
BohenzkyR. A.,
ChienM.-C.8 other authors1996; Nucleotide sequence of the Kaposi's sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93:14862–14867
SchepersA.,
PichD.,
HammerschmidtW.1996; Activation of oriLyt, the lytic origin of DNA replication of Epstein–Barr virus, by BZLF1. Virology 220:367–376
SeamanW. T.,
YeD. S.,
WangR. X.,
HaleE. E.,
WeisseM.,
QuinlivanE. B.1999; Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus. Virology 263:436–449
SistaN. D.,
PaganoJ. S.,
LiaoW.,
KenneyS.1993; Retinoic acid is a negative regulator of the Epstein–Barr virus protein (BZLF1) that mediates disruption of latent infection. Proc Natl Acad Sci U S A 90:3894–3898
SistaN. D.,
BarryC.,
SampsonK.,
PaganoJ.1995; Physical and functional interaction of the Epstein–Barr virus BZLF1 transactivator with the retinoic acid receptors RAR α and RXR α
. Nucleic Acids Res 23:1729–1736
SunR.,
LinS. F.,
GradovilleL.,
YuanY.,
ZhuF. X.,
MillerG.1998; A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 95:10866–10871
ThompsonJ. D.,
HigginsD. G.,
GibsonT. J.1994; clustal w: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680
WangS. E.,
WuF. Y.,
FujimuroM.,
ZongJ.,
HaywardS. D.,
HaywardG. S.2003; Role of CAAT/enhancer-binding protein α (C/EBP α ) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP. J Virol 77:600–623
WuF. Y.,
AhnJ. H.,
AlcendorD. J.,
JangW. J.,
XiaoJ.,
HaywardS. D.,
HaywardG. S.2001; Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML. J Virol 75:1487–1506
WuF. Y.,
ChenH.,
WangS. E.7 other authors2003; CCAAT/enhancer binding protein α interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G1 cell cycle arrest during the Epstein–Barr virus lytic cycle. J Virol 77:1481–1500
ZhangQ.,
GutschD.,
KenneyS.1994; Functional and physical interaction between p53 and BZLF1: implications for Epstein–Barr virus latency. Mol Cell Biol 14:1929–1938